Maury Raycroft
Stock Analyst at Jefferies
(4.52)
# 1,045
Out of 5,133 analysts
239
Total ratings
42%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTY City Therapeutics | Initiated Coverage: Buy | $32 | $18.10 | +76.80% | 1 | Nov 10, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $41 → $49 | $22.83 | +114.63% | 2 | Nov 3, 2026 | |
| CADL Candel Therapeutics | Initiated Coverage: Buy | $25 | $6.20 | +303.23% | 1 | Oct 22, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | $112 | $111.19 | +0.73% | 6 | Oct 5, 2026 | |
| QTTB Q32 Bio | Reiterated: Buy | $29 | $8.71 | +232.95% | 2 | Oct 1, 2026 | |
| ANL Adlai Nortye Group | Initiated Coverage: Buy | $31 | $10.61 | +192.18% | 1 | Sep 10, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $77 → $28 | $16.08 | +74.13% | 16 | Sep 3, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $47 → $10 | $1.47 | +580.27% | 2 | Aug 6, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $44 → $42 | $20.03 | +109.74% | 7 | Aug 5, 2026 | |
| KPTIQ Karyopharm Therapeutics Inc. | Reiterated: Buy | $11 | $0.0254 | +43,207.09% | 1 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $24 | $15.66 | +53.26% | 3 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $47 | $40.86 | +15.03% | 3 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $27 → $60 | $25.50 | +135.29% | 3 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $132 | $91.81 | +43.78% | 6 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $33 | $3.39 | +873.45% | 7 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.37 | +256.08% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $0.7738 | +1,063.09% | 4 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $52 | $31.83 | +63.37% | 2 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $5.66 | +165.02% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $2.41 | +1,061.83% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $3.66 | +447.20% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $15.73 | n/a | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.68 | n/a | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $549 | $165.04 | n/a | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $7.61 | n/a | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $50.65 | n/a | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $79 | $64.37 | n/a | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $23 | $7.86 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $0.7261 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.10 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $9 | $4.27 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $15 | $6.84 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $1.5 | $0.117 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.3075 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $0.6917 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $20 | $0.0001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $16.12 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.3819 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $28.10 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $47.78 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $42.24 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $0.6012 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $109 | $9.70 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $25 | $7.70 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $86 | $24.60 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.57 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $40.48 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $2.42 | n/a | 2 | May 22, 2018 |
City Therapeutics
Nov 10, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $18.10
Upside: +76.80%
Beam Therapeutics
Nov 3, 2026
Reiterated: Buy
Price Target: $41 → $49
Current: $22.83
Upside: +114.63%
Candel Therapeutics
Oct 22, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $6.20
Upside: +303.23%
Kodiak Sciences
Oct 5, 2026
Reiterated: Buy
Price Target: $112
Current: $111.19
Upside: +0.73%
Q32 Bio
Oct 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.71
Upside: +232.95%
Adlai Nortye Group
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $10.61
Upside: +192.18%
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Buy
Price Target: $77 → $28
Current: $16.08
Upside: +74.13%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $47 → $10
Current: $1.47
Upside: +580.27%
Tyra Biosciences
Aug 5, 2026
Reiterated: Buy
Price Target: $44 → $42
Current: $20.03
Upside: +109.74%
Karyopharm Therapeutics Inc.
Jul 31, 2026
Reiterated: Buy
Price Target: $11
Current: $0.0254
Upside: +43,207.09%
Jul 14, 2026
Rated: Buy
Price Target: $21 → $24
Current: $15.66
Upside: +53.26%
Jul 13, 2026
Reiterated: Buy
Price Target: $39 → $47
Current: $40.86
Upside: +15.03%
Jun 26, 2026
Upgraded: Buy
Price Target: $27 → $60
Current: $25.50
Upside: +135.29%
Jun 15, 2026
Reiterated: Buy
Price Target: $132
Current: $91.81
Upside: +43.78%
May 12, 2026
Reiterated: Buy
Price Target: $53 → $33
Current: $3.39
Upside: +873.45%
Apr 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.37
Upside: +256.08%
Apr 27, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $0.7738
Upside: +1,063.09%
Apr 5, 2026
Reiterated: Buy
Price Target: $14 → $52
Current: $31.83
Upside: +63.37%
Mar 23, 2026
Reiterated: Buy
Price Target: $14 → $15
Current: $5.66
Upside: +165.02%
Feb 25, 2026
Reiterated: Buy
Price Target: $28
Current: $2.41
Upside: +1,061.83%
Dec 8, 2025
Reiterated: Buy
Price Target: $15 → $20
Current: $3.66
Upside: +447.20%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $15.73
Upside: n/a
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.68
Upside: n/a
Oct 30, 2025
Reiterated: Buy
Price Target: $384 → $549
Current: $165.04
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: $14 → $15
Current: $7.61
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $50.65
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $33 → $79
Current: $64.37
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $40 → $23
Current: $7.86
Upside: n/a
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $0.7261
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $8
Current: $4.10
Upside: n/a
May 19, 2025
Reiterated: Buy
Price Target: $15 → $9
Current: $4.27
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $7 → $15
Current: $6.84
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $2 → $1.5
Current: $0.117
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.3075
Upside: n/a
Nov 13, 2024
Rated: Buy
Price Target: $21
Current: $0.6917
Upside: n/a
Apr 4, 2024
Reiterated: Buy
Price Target: $10 → $20
Current: $0.0001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $16.12
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $0.3819
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $28.10
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $75
Current: $47.78
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $42.24
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $0.6012
Upside: n/a
Jun 22, 2021
Reiterated: Buy
Price Target: $37 → $109
Current: $9.70
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $14 → $25
Current: $7.70
Upside: n/a
Jul 29, 2020
Reiterated: Buy
Price Target: $34 → $86
Current: $24.60
Upside: n/a
May 18, 2020
Reiterated: Buy
Price Target: $25
Current: $7.57
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $40.48
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $2.42
Upside: n/a